Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection

NCT06084351 is registered in ClinicalTrials.gov with Larkin Community Hospital as lead sponsor.

NCT NCT06084351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06084351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
Lead sponsor
Larkin Community Hospital
Phase
Phase 3
Overall status
Withdrawn
Start date
May 12, 2020
Completion date
October 30, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19